Pfizer Files Suit Over Fake Viagra Web Sales
- Share via
Pfizer Inc. sued five Internet pharmacies and sought to seize the domain names of more than two dozen others to stop the sale of counterfeit Viagra, the top-selling male impotence drug.
Pfizer filed the lawsuits in the U.S. District Court for the Southern District of New York, Jeff Kindler, Pfizer’s general counsel, said. The New York-based company said it was working with U.S. government agencies to block the counterfeit drug sales.
Viagra’s worldwide revenue dropped 7% to $389 million in the second quarter, Pfizer reported.
Shares of Pfizer rose 25 cents to $32.45 on the NYSE.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
